Since SATB1 expression is strongly up-regulated in various types of cancer, SATB1565–574 may serve as a diagnostic tool or an immunotherapeutic target of cancer vaccines for ovarian cancer, lymphoma and other types of cancer. Here, SATB1 is linked to ovarian carcinoma.